VitaDAO
VitaDAO is a pioneering decentralized autonomous organization (DAO) dedicated to funding and advancing early-stage longevity research. As a leader in the decentralized science (DeSci) movement, VitaDAO uses blockchain technology and IP-NFTs to fund research projects and create a community-owned portfolio of longevity assets. Notable for being the first DAO to receive investment from a major pharmaceutical company (Pfizer Ventures).
Website
https://www.vitadao.comLocation
Decentralized (Global)
Founded
2021
AUM
$10M+ (treasury)
Investment Range
$50K - $500K
Portfolio Companies
7
Focus
dao
Fund Stages
seed
Portfolio Companies
| Name | Location | Founded | Categories |
|---|---|---|---|
| Matrix Biosciences | Rochester, New York, USA | 2023 | therapeuticsbiotech+3 |
| Turn Biotechnologies | Mountain View, California, USA | 2018 | therapeuticsbiotech+3 |
| Rubedo Life Sciences | Sunnyvale, California, USA | 2019 | therapeuticsbiotech+3 |
| ExcepGen Inc | - | - | therapeuticsbiotech+3 |
| GERO | Singapore | 2015 | ai-drug-discoverylongevity-research+2 |
| Oisín Biotechnologies | Seattle, Washington, USA | 2016 | biotechlongevity+3 |
| ApoptoSENS | United States | 2022 | biotechlongevity+3 |